Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Shanghai Stock Exchange 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Operating Income Margin for the year ending December 31, 2023: 21.29%

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Operating Income Margin is 21.29% for the year ending December 31, 2023, a 4.62% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Operating Income Margin for the year ending December 31, 2022 was 20.35%, a 9.70% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Operating Income Margin for the year ending December 31, 2021 was 18.55%, a 7.64% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Operating Income Margin for the year ending December 31, 2020 was 17.23%, a 21.75% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Operating Income Margin for the year ending December 31, 2019 was 14.15%, a 36.04% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

Shanghai Stock Exchange: 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd

CEO	Mr. Yi Jiang Mei
IPO Date	Oct. 10, 2014
Location	China
Headquarters	99 Waisha Road
Employees	4,877
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Personal Care Petrochemicals Plastics

Description

Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Key trends

Past 5 years